# Haleon US Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/haleon-us-inc/59f65cda-88dc-4ec6-98a9-42bd852cb203

> Inspection records and compliance data for Haleon US Inc. in Lincoln, Nebraska. Access full analysis and detailed observations.

---

## Details

- Name: Haleon US Inc.
- FEI Number: 1911445
- City: Lincoln
- State: Nebraska
- Country Name: United States
- Address Line 1: 10401 Us Highway 6
- Zip Code: 68517
- Facility Type: Drug Manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1229361 - Haleon US Inc. - 2024-09-11](https://www.globalkeysolutions.net/records/fda_inspections/haleon-us-inc/94241363-9d05-471f-988a-314ca9ff7424) — source: FDA, date: September 11, 2024
- [FDA Inspection 1229361 - Haleon US Inc. - 2024-09-11](https://www.globalkeysolutions.net/records/fda_inspections/haleon-us-inc/20da85d3-6031-45a0-a901-6c26804f859b) — classification: No Action Indicated (NAI), source: FDA, date: September 11, 2024
- [FDA Inspection 1229361 - Haleon US Inc. - 2024-09-11](https://www.globalkeysolutions.net/records/fda_inspections/haleon-us-inc/af6a15df-128f-4305-bd0c-be11a0621ea8) — classification: No Action Indicated (NAI), source: FDA, date: September 11, 2024
- [483 - Haleon US Inc. - 2021-09-30](https://www.globalkeysolutions.net/records/483/haleon-us-inc/62f851a1-563f-4ffc-a4ec-eb6f8d67e1b3) — source: FDA, date: September 30, 2021
- [FDA Inspection 1153381 - Haleon US Inc. - 2021-09-30](https://www.globalkeysolutions.net/records/fda_inspections/haleon-us-inc/9105700c-cace-4bbb-b02c-5da74d0e2f3f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 30, 2021
- [FDA Inspection 1117667 - Haleon US Inc. - 2019-12-04](https://www.globalkeysolutions.net/records/fda_inspections/haleon-us-inc/0725248b-59d3-4bd7-bc1d-dd5ad53868b3) — classification: No Action Indicated (NAI), source: FDA, date: December 4, 2019
- [FDA Inspection 1013216 - Haleon US Inc. - 2017-05-25](https://www.globalkeysolutions.net/records/fda_inspections/haleon-us-inc/7fd1b6b1-bda5-45d4-add1-8a4933ef301a) — classification: No Action Indicated (NAI), source: FDA, date: May 25, 2017
- [FDA Inspection 1013216 - Haleon US Inc. - 2017-05-25](https://www.globalkeysolutions.net/records/fda_inspections/haleon-us-inc/12181fb4-7e5c-4079-8c58-0678cf79d797) — classification: No Action Indicated (NAI), source: FDA, date: May 25, 2017
- [FDA Inspection 1008528 - Haleon US Inc. - 2017-02-22](https://www.globalkeysolutions.net/records/fda_inspections/haleon-us-inc/27cb4ecb-419d-4454-81b7-e35f4e161fbd) — classification: No Action Indicated (NAI), source: FDA, date: February 22, 2017
- [FDA Inspection 987426 - Haleon US Inc. - 2016-08-30](https://www.globalkeysolutions.net/records/fda_inspections/haleon-us-inc/6a5f5c43-71ad-49e9-941e-48f8c85cfd72) — classification: No Action Indicated (NAI), source: FDA, date: August 30, 2016
- [FDA Inspection 987426 - Haleon US Inc. - 2016-08-30](https://www.globalkeysolutions.net/records/fda_inspections/haleon-us-inc/05740685-6764-487e-9f23-19e953feffde) — classification: No Action Indicated (NAI), source: FDA, date: August 30, 2016
- [483 - Haleon US Inc. - 2013-02-14](https://www.globalkeysolutions.net/records/483/haleon-us-inc/77ad0d4e-a7bd-460b-ba38-1a7299e89a9d) — source: FDA, date: February 14, 2013
- [483 - Haleon US Inc. - 2011-07-08](https://www.globalkeysolutions.net/records/483/haleon-us-inc/64a8b65b-0f2c-4329-bbdc-9e75dc0aac4f) — source: FDA, date: July 8, 2011

## Related Companies

- [Takeda GmbH, Plant Oranienburg](https://www.globalkeysolutions.net/companies/takeda-gmbh-plant-oranienburg/c72ad117-1d9b-474a-8d1a-c4d0e81e9ba8)
- [Siegfried El Masnou, S.A.](https://www.globalkeysolutions.net/companies/siegfried-el-masnou-sa/7d454af3-32c0-4c5d-b7cb-c11d6cd5096b)
- [Thymoorgan Pharmazie Gmbh](https://www.globalkeysolutions.net/companies/thymoorgan-pharmazie-gmbh/b58b84eb-57d4-4730-8fbb-58632f71023d)
- [Merck Serono S.p.A.](https://www.globalkeysolutions.net/companies/merck-serono-spa/052a4b09-0189-4f5c-bdcc-33182a7d3488)
- [Alphapharm Pty, Ltd.](https://www.globalkeysolutions.net/companies/alphapharm-pty-ltd/9007b3c5-9b83-4783-b65d-52eb0246708e)
- [Cadila Pharmaceuticals Limited](https://www.globalkeysolutions.net/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9)
- [AstraZeneca Pharmaceuticals LP](https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06)
- [Patheon Inc.](https://www.globalkeysolutions.net/companies/patheon-inc/76561a83-edb8-4c76-934b-6b2bd5e67949)
- [Lilly France S.A.S.](https://www.globalkeysolutions.net/companies/lilly-france-sas/27fa7368-5fb0-48b1-b161-5729c7bfa061)
- [Anesta LLC](https://www.globalkeysolutions.net/companies/anesta-llc/821f19a7-cabd-47ab-a635-7880a3c5046d)

## Related Officers

- [Eric Mueller](https://www.globalkeysolutions.net/people/eric-mueller/c2da0580-e8b7-41d8-94b6-3579d2bfad8b)
- [Compliance Officer, CDER, Office of Manufacturing](https://www.globalkeysolutions.net/people/joseph-r-lambert/d2968fda-8e5e-433a-b60b-f68aaef3b7b0)
- [Investigator](https://www.globalkeysolutions.net/people/e-moore/0d2411c5-b9e3-4358-9dab-0a5f253a157a)
- [Consumer Safety Officer/ Federal Investigator](https://www.globalkeysolutions.net/people/lisa-l-flores/465a6807-55d7-4c3f-a415-c21ac4517bc9)
- [Drug National Expert](https://www.globalkeysolutions.net/people/sandra-a-boyd/c469103a-0917-407a-b9d1-98273358dfeb)